{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:04:19Z","timestamp":1768280659563,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.breast.2016.11.025","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T20:15:53Z","timestamp":1481573753000},"page":"233-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?"],"prefix":"10.1016","volume":"31","author":[{"given":"Stephanie","family":"Tesson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imogen","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly-Anne","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni","family":"Musiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Marven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis","family":"Butow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2016.11.025_bib1","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2001.19.19.3938","article-title":"Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer","volume":"19","author":"McDonnell","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2016.11.025_bib2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.surge.2014.02.005","article-title":"Increasing trend of contralateral prophylactic mastectomy: what are the factors behind this phenomenon?","volume":"12","author":"Soran","year":"2014","journal-title":"Surgeon"},{"key":"10.1016\/j.breast.2016.11.025_bib3","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/jama.2014.10707","article-title":"Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998-2011","volume":"312","author":"Kurian","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2016.11.025_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","article-title":"Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation","volume":"345","author":"Meijers-Heijboer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2016.11.025_bib5","first-page":"348","article-title":"Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis","author":"Metcalfe","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.breast.2016.11.025_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrclinonc.2014.3","article-title":"Bilateral breast cancers","volume":"11","author":"Narod","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.breast.2016.11.025_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.breast.2010.10.004","article-title":"Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort","volume":"20","author":"Beckmann","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.breast.2016.11.025_bib8","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/jnci\/djq058","article-title":"Contralateral second breast cancers: prediction and prevention","volume":"102","author":"Brenner","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2016.11.025_bib9","first-page":"11","article-title":"Prophylactic mastectomy for the prevention of breast cancer","author":"Lostumbo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.breast.2016.11.025_bib10","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","article-title":"Metastatic behavior of breast cancer subtypes","volume":"28","author":"Kennecke","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2016.11.025_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jncimonographs\/lgi039","article-title":"Complications following bilateral prophylactic mastectomy","volume":"2005","author":"Barton","year":"2005","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"key":"10.1016\/j.breast.2016.11.025_bib12","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1245\/s10434-011-1917-7","article-title":"Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits","volume":"18","author":"Frost","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2016.11.025_bib13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s10434-999-0542-1","article-title":"Issues of regret in women with contralateral prophylactic mastectomies","volume":"6","author":"Montgomery","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2016.11.025_bib14","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1200\/JCO.2010.29.4041","article-title":"Clinical management factors contribute to the decision for contralateral prophylactic mastectomy","volume":"29","author":"King","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2016.11.025_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1586\/14737140.2014.883284","article-title":"Contralateral prophylactic mastectomy: are we overtreating patients?","volume":"14","author":"Burke","year":"2014","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.breast.2016.11.025_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.7326\/0003-4819-159-6-201309170-00003","article-title":"Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey","volume":"159","author":"Rosenberg","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.breast.2016.11.025_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.breast.2012.06.005","article-title":"Risk, worry and cosmesis in decision-making for contralateral risk-reducing mastectomy: analysis of 60 consecutive cases in a specialist breast unit","volume":"22","author":"Beesley","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.breast.2016.11.025_bib18","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.pec.2015.11.012","article-title":"Women's preferences for contralateral prophylactic mastectomy: an investigation using protection motivation theory","volume":"99","author":"Tesson","year":"2016","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.breast.2016.11.025_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejon.2015.12.002","article-title":"Predicting women's intentions for contralateral prophylactic mastectomy: an application of an extended theory of planned behaviour","volume":"21","author":"Richards","year":"2016","journal-title":"Eur J Oncol Nurs"},{"key":"10.1016\/j.breast.2016.11.025_bib20","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1158\/1940-6207.CAPR-09-0130","article-title":"Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy","volume":"3","author":"Yi","year":"2010","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.breast.2016.11.025_bib21","first-page":"1","article-title":"Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy","author":"Ashfaq","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2016.11.025_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/PSN.0b013e3182842424","article-title":"The contralateral prophylactic mastectomy decision-making process","volume":"33","author":"Baker","year":"2013","journal-title":"Plast Surg Nurs"},{"key":"10.1016\/j.breast.2016.11.025_bib23","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1016\/S1470-2045(13)70047-0","article-title":"Contralateral risk-reducing mastectomy in sporadic breast cancer","volume":"14","author":"Murphy","year":"2013","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.breast.2016.11.025_bib24","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/annonc\/mdr559","article-title":"Preferences for cancer treatments: an overview of methods and applications in oncology","volume":"23","author":"Blinman","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2016.11.025_bib25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1470-2045(05)70254-0","article-title":"What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?","volume":"6","author":"Thewes","year":"2005","journal-title":"lancet Oncol"},{"key":"10.1016\/j.breast.2016.11.025_bib26","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/annonc\/mdi370","article-title":"Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?","volume":"16","author":"Duric","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2016.11.025_bib27","first-page":"153","article-title":"Cognitive and physiological processes in fear appeals and attitude change: a revised theory of protection motivation","author":"Rogers","year":"1983","journal-title":"Soc Psychophysiol"},{"key":"10.1016\/j.breast.2016.11.025_bib28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/2193-1801-3-264","article-title":"Women's preferences for selective estrogen reuptake modulators: an investigation using the time trade off technique","volume":"3","author":"Ralph","year":"2014","journal-title":"SpringerPlus"},{"key":"10.1016\/j.breast.2016.11.025_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/08870449808406749","article-title":"Can protection motivation theory predict behaviour? A longitudinal test exploring the role of previous behaviour","volume":"13","author":"Hodgkins","year":"1998","journal-title":"Psychol Health"},{"key":"10.1016\/j.breast.2016.11.025_bib30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1006\/pmed.2002.1110","article-title":"Application of the protection motivation theory to genetic testing for breast cancer risk","volume":"35","author":"Helmes","year":"2002","journal-title":"Prev Med"},{"key":"10.1016\/j.breast.2016.11.025_bib31","unstructured":"Institute NC. NCI dictionary of cancer terms. In. http:\/\/cancer.gov\/dictionary: 2012."},{"key":"10.1016\/j.breast.2016.11.025_bib32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/oxfordjournals.jncimonographs.a003453","article-title":"Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?","author":"Simes","year":"2001","journal-title":"J\u00a0Natl Cancer Inst Monogr 2001"},{"key":"10.1016\/j.breast.2016.11.025_bib33","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/pon.2037","article-title":"The influence of knowledge and perception of the risk of cervical cancer on screening behavior in mainland Chinese women","volume":"21","author":"Gu","year":"2012","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.breast.2016.11.025_bib34","first-page":"241","article-title":"Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence","volume":"17","author":"Simard","year":"2009","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.breast.2016.11.025_bib35","article-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"2013","journal-title":"Routledge Acad"},{"key":"10.1016\/j.breast.2016.11.025_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3758\/BF03203630","article-title":"GPOWER: a general power analysis program","volume":"28","author":"Erdfelder","year":"1996","journal-title":"Behav Res methods, Instrum Comput"},{"key":"10.1016\/j.breast.2016.11.025_bib37","first-page":"360","article-title":"Understanding interobserver agreement: the kappa statistic","volume":"37","author":"Viera","year":"2005","journal-title":"Fam Med"},{"key":"10.1016\/j.breast.2016.11.025_bib38","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1445-2197.2012.06209.x","article-title":"Breast surgeons' perceptions and attitudes towards contralateral prophylactic mastectomy","volume":"83","author":"Musiello","year":"2012","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.breast.2016.11.025_bib39","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1054\/bjoc.2001.1836","article-title":"Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?","volume":"84","author":"Jansen","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2016.11.025_bib40","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/jnci\/93.13.979","article-title":"National institutes of health consensus development conference statement: adjuvant therapy for breast cancer, November 1\u20133, 2000","volume":"93","author":"NIoHCD","year":"2001","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.breast.2016.11.025_bib41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11912-009-0070-y","article-title":"The increasing use of prophylactic mastectomy in the prevention of breast cancer","volume":"12","author":"Tuttle","year":"2010","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.breast.2016.11.025_bib42","series-title":"A\u00a0theory of cognitive dissonance","author":"Festinger","year":"1962"},{"key":"10.1016\/j.breast.2016.11.025_bib43","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1200\/JCO.2007.16.0101","article-title":"Are cancer-related decision aids effective? A systematic review and meta-analysis","volume":"27","author":"O'Brien","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2016.11.025_bib44","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/154099903322447738","article-title":"Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer","volume":"12","author":"Meiser","year":"2003","journal-title":"J\u00a0Womens Health"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977616302594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977616302594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:38:07Z","timestamp":1760776687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977616302594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":44,"alternative-id":["S0960977616302594"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2016.11.025","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2016.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}